DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹1,156 Cr | ₹794 Cr | ₹715 Cr | ₹1,509 Cr | ₹761 Cr |
What is the latest Short Term Loans and Advances ratio of DIVIS LABORATORIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2025 | ₹1,156 Cr |
Mar2024 | ₹794 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹1,509 Cr |
Mar2021 | ₹761 Cr |
How is Short Term Loans and Advances of DIVIS LABORATORIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2025 | ₹1,156 Cr | 45.59 | |
Mar2024 | ₹794 Cr | 11.05 | |
Mar2023 | ₹715 Cr | -52.63 | |
Mar2022 | ₹1,509 Cr | 98.37 | |
Mar2021 | ₹761 Cr | - |
Compare Short Term Loans and Advances of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹168,831.5 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
MANKIND PHARMA | ₹105,753.0 Cr | 0.8% | 8.4% | 26.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -3.3% |
-7.4% |
34.1% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses